Welcome to our dedicated page for ASAHI KAISEI CRP UNSP/ADR news (Ticker: AHKSY), a resource for investors and traders seeking the latest updates and insights on ASAHI KAISEI CRP UNSP/ADR stock.
Asahi Kasei Corporation (symbol: AHKSY) is a diversified Japanese technology and manufacturing company dedicated to contributing to life and living globally. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has continuously transformed its business portfolio to meet evolving market demands. The company operates through three primary sectors: Material, Homes, and Health Care.
In the Material sector, Asahi Kasei produces a wide array of products, including battery separators, biodegradable textiles, engineering plastics, and sound solutions. Recently, the company announced a significant investment in an integrated plant in Ontario, Canada, for manufacturing Hipore™ wet-process lithium-ion battery separators, in partnership with Honda and the Development Bank of Japan.
In the Health Care sector, Asahi Kasei focuses on devices and systems for acute critical care, dialysis, therapeutic apheresis, and the manufacturing of biotherapeutics. The company recently completed the construction of its third assembly plant for Planova™ virus removal filters in Japan and announced the launch of a new plasmid DNA manufacturing facility in Texas, USA, through its subsidiary, Bionova Scientific.
Asahi Kasei is also making strides in the renewable energy sector with its hydrogen business. The company celebrated the opening of a new hydrogen pilot plant in Kawasaki, Japan, marking a significant milestone toward commercializing large-scale alkaline water electrolysis systems for green hydrogen production.
In addition to these advancements, Asahi Kasei is committed to sustainability, aiming to reach carbon neutrality by 2050. The company's R&D initiatives include the development of high ionic conductive electrolytes for lithium-ion batteries, which promise enhanced performance and durability at extreme temperatures.
Asahi Kasei's recent partnership with Axolabs to establish a cutting-edge oligonucleotide cGMP manufacturing facility in Berlin underscores its commitment to innovation in the biopharmaceutical industry. This collaboration aims to accelerate the development and commercialization of oligonucleotide-based therapies to improve patient quality of life globally.
With over 48,000 employees worldwide, Asahi Kasei continues to be a global leader in providing innovative solutions to the world's challenges, ensuring sustainable growth and development.
Asahi Kasei and Microwave Chemical have initiated a joint project to commercialize a chemical recycling process for polyamide 66 (PA66) using microwave technology, launched in April 2023. This process involves depolymerizing PA66 to directly extract high-yield monomers hexamethylenediamine (HMD) and adipic acid (ADA) with low energy consumption. The project aims to reduce greenhouse gas emissions in PA66 production, leveraging Microwave Chemical's PlaWave™ technology. Laboratory studies confirmed successful depolymerization of PA66, and plans for bench-scale equipment are underway at the Osaka Factory to further validate the process through a small-scale demonstration trial in fiscal 2024. A decision on commercialization will follow by fiscal 2025.
Asahi Kasei Bioprocess America and GeminiBio have formed a strategic partnership to enhance inline buffer formulation (IBF) in the biopharmaceutical industry. This collaboration aims to streamline buffer management, thereby reducing production bottlenecks and costs, increasing productivity, and improving medication accessibility globally. The partnership, initiated in March 2023, combines Asahi Kasei's MOTIV IBF™ system with GeminiBio's pre-mixed concentrates, creating a comprehensive solution for biopharmaceutical manufacturers. The synergy is expected to foster innovation and set new industry standards, benefiting manufacturers by simplifying processes and ensuring timely buffer production.
Asahi Kasei has established a new investment framework named “Care for Earth,” committing
The investment is part of Asahi Kasei's long-term strategy to enhance its corporate venture capital (CVC) activity, which has been ongoing since 2008 and has seen over 50 startup investments across various global markets. The framework signifies a shift towards addressing longer-term commercial prospects in sustainability, complementing existing healthcare-focused investments.
Asahi Kasei aims to significantly reduce its greenhouse gas emissions and contribute to a sustainable future by 2050, ultimately transforming its material sector portfolio.
Asahi Kasei's Nonwovens Plant in Nobeoka, Japan, has received the first Renewable Energy Use Certification from Japan's Powered by RE Certification Committee, validating that its Dinamica® production facility operates on 100% renewable energy since March 8, 2023. This initiative aligns with global sustainability goals and carbon neutrality efforts, as Asahi Kasei aims to achieve carbon neutrality by 2050. Dinamica®, an artificial suede widely used in automotive interiors, furniture, and industrial materials, exemplifies high-value products made from renewable resources. The certification enhances Asahi Kasei's commitment to environmental responsibility and market competitiveness.
Asahi Kasei and its subsidiary Crystal IS have introduced a new next-generation Klaran single-chip UVC LED that emits 160 mW in the germicidal range of 260-270 nm. This breakthrough represents a 60% increase over previous models, enhancing the efficiency in replacing low-pressure mercury lamps. The compact design remains compatible with existing systems, while the improved output facilitates broader applications in water and air treatment. The new UVC LEDs utilize a rigid fused silica lens for better light transmission and longevity. Commercial release is anticipated later in 2023.
Asahi Kasei and its subsidiary, Crystal IS, have released lifetime characterization data for the Klaran LA UVC LED after over 10,000 hours of testing. The results show a projected L70 lifetime of over 25,000 hours at a temperature of 35°C, exceeding traditional low-pressure mercury lamps. This innovation aims to assist partner companies in water, air, and surface treatment, emphasizing the company's commitment to effective disinfection technology. Eoin Connolly, CEO of Crystal IS, highlighted the significant performance and reliability of Klaran products, reinforcing the brand's reputation for quality in the UVC LED market.
FAQ
What is the current stock price of ASAHI KAISEI CRP UNSP/ADR (AHKSY)?
What is the market cap of ASAHI KAISEI CRP UNSP/ADR (AHKSY)?
What sectors does Asahi Kasei operate in?
What recent projects has Asahi Kasei announced?
What is Asahi Kasei's commitment to sustainability?
Who are Asahi Kasei's key partners in recent ventures?
What are Asahi Kasei's contributions to the biopharmaceutical industry?
Where is Asahi Kasei's new hydrogen pilot plant located?
What is the Hipore™ wet-process separator used for?
How does Asahi Kasei support innovation in manufacturing?
What are the benefits of Asahi Kasei's high ionic conductive electrolyte?
How many employees does Asahi Kasei have globally?
